- Conditions
- Idiopathic Parkinson's Disease
- Interventions
- Rotigotine
- Drug
- Lead sponsor
- UCB Pharma
- Industry
- Eligibility
- 31 Years and older
- Enrollment
- 186 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 9
- States / cities
- Birmingham, Alabama • St. Petersburg, Florida • Fort Wayne, Indiana + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–37
of 13
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Restless Legs Syndrome
- Interventions
- Rotigotine
- Drug
- Lead sponsor
- UCB BIOSCIENCES, Inc.
- Industry
- Eligibility
- 13 Years and older
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 5
- States / cities
- Los Angeles, California • Orange, California • Spring Hill, Florida + 2 more
- Conditions
- Parkinson's Disease
- Interventions
- ROTIGOTINE
- Drug
- Lead sponsor
- Luye Pharma Group Ltd.
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 3
- States / cities
- Long Beach, California • Hallandale, Florida • Atlanta, Georgia
- Conditions
- Advanced Idiopathic Parkinson's Disease
- Interventions
- Rotigotine
- Drug
- Lead sponsor
- UCB BIOSCIENCES GmbH
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 87 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 6
- States / cities
- Anniston, Alabama • Atlantis, Florida • Miami Springs, Florida + 3 more
- Conditions
- Restless Legs Syndrome
- Interventions
- Rotigotine
- Drug
- Lead sponsor
- UCB BIOSCIENCES, Inc.
- Industry
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 12
- States / cities
- Little Rock, Arkansas • Los Angeles, California • Orange, California + 9 more
- Conditions
- Substance-Related Disorders
- Interventions
- Rotigotine Transdermal System [Neupro], Placebo
- Drug
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 25 Years to 70 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
- Interventions
- Rotigotine patch
- Drug
- Lead sponsor
- UCB Pharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 520 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 51
- States / cities
- Birmingham, Alabama • Cullman, Alabama • Fairhope, Alabama + 46 more
- Conditions
- Fibromyalgia Syndrome
- Interventions
- Rotigotine, Placebo
- Drug · Other
- Lead sponsor
- UCB Pharma
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 230 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 35
- States / cities
- Mobile, Alabama • Mesa, Arizona • Peoria, Arizona + 32 more
- Conditions
- Restless Legs Syndrome
- Interventions
- buprenorphine transdermal delivery system (BTDS), Placebo for BTDS patch
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 25 Years to 75 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch
- Interventions
- Rotigotine Transdermal System
- Drug
- Lead sponsor
- Inflamax Research Incorporated
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 260 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Post-op Pain
- Interventions
- Neupro® transdermal patch/placebo
- Drug
- Lead sponsor
- East Carolina University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Greenville, North Carolina
- Conditions
- Restless Legs Syndrome
- Interventions
- Rotigotine, Placebo
- Drug · Other
- Lead sponsor
- UCB Pharma
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • Jasper, Alabama • Gilbert, Arizona + 15 more
- Conditions
- Idiopathic Parkinson's Disease
- Interventions
- Rotigotine, Placebo
- Drug · Other
- Lead sponsor
- UCB BIOSCIENCES GmbH
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 122 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 25
- States / cities
- Birmingham, Alabama • Oxnard, California • Ormond Beach, Florida + 21 more